Publications

Filters
April 21, 2016

FGFR selective inhibitor Debio1347 induces tumor regressions in FGFR2-altered gastric cancer PDX models

Read more
April 11, 2016

Activity of Debio 1452 against Staphylococcus spp. collected in 2013 / 2014

Read more
April 11, 2016

Activity of the novel Fabl inhibitor Debio 1452 against intracellular forms of susceptible and resistant S. aureus: comparison with linezolid,…

Read more
December 28, 2015

Efficacy and Safety Of AFN-1252, The First Staphylococcus-Specific Antibacterial Agent, in The Treatment of Acute Bacterial Skin And Skin Structure…

Read more
November 8, 2015

Clinical Safety, Pharmacokinetics and Early Evidence of Activity of The Oral IAPs Inhibitor Debio 1143 in Combination with Carboplatin and…

Read more
October 23, 2015

SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells

Read more
September 21, 2015

The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNF-alpha-mediated in head and neck squamous cell carcinoma.

Read more
September 19, 2015

Single Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a FabI Inhibitor, the Prodrug Debio 1450 and…

Read more
September 11, 2015

Safety, tolerability and pharmacokinetics of AFN–1252 administered as immediate release tablets in healthy subjects

Read more